Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02853643 · ClinicalTrials.gov registry record · Phase 1
Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers
A Phase 1 study, sponsored by Asana BioSciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT02853643: Completed Phase 1 study, sponsored by Asana BioSciences.
NCT02853643 is a Phase 1 study that has completed, run by Asana BioSciences. The registered enrollment target is 22 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02853643, a Phase 1 study, has completed, sponsored by Asana BioSciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability, and determine the blood levels (pharmacokinetics), in both a fed and fasted condition, of a single dose of ASN002. Healthy volunteers will be participants in the study.
Primary Outcome
Safety and tolerability will be determined by the number of subjects reporting adverse events during the study.
Interventions
- DRUG ASN002
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-07 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
What the finished NCT02853643 record still lists
NCT02853643 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 1 intervention - of which ASN002 is the first listed.
NCT02853643 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02853643 about?
NCT02853643 is a clinical study titled "Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers". The purpose of this study is to evaluate the safety and tolerability, and determine the blood levels (pharmacokinetics), in both a fed and fasted condition, of a single dose of ASN002. Healthy volunteers will be participants in the study.
What is the current status of trial NCT02853643?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2016-07. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02853643?
The interventions under investigation include: ASN002 (DRUG).
Who is sponsoring clinical trial NCT02853643?
This trial is sponsored by Asana BioSciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02853643's enrollment target sits among peer trials
22 1601st of 2000 higher than 386 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia